The aim of this triple blind randomized controlled trial will be theassociation of the effects of probiotic supplement on anthropometric measurements, metabolic syndrome components, gastrointestinal hormones and inflammatory factors in patients with metabolic syndrome. 46 patients aged 25-70,from both sexes, who do not use antibiotic from 1 month before the study and who do not use Insulin, oral contraceptive drugs or corticosteroids, will randomly categorize into intervention or placebo group. The intervention group will consume 2 probiotic capsules (250 mg) product of PROTEXIN, for 3 months. The placebo group will consume placebo capsules, in number and duration similar to intervention group. Both groups will receive a weight loss diet, according to the adjusted ideal body weight. Anthropometric, nutritional, biochemical (fasting blood glucose, lipid profile, hs-CRP, PYY, GLP-1) and blood pressure measurements will done in the beginning and at the end of the study.